Company Filing History:
Years Active: 2008
Title: Innovations in Tumor Imaging by Douglas J Rowland, Jr.
Introduction
Douglas J Rowland, Jr. is an accomplished inventor based in Shrewsbury, MO (US). He has made significant contributions to the field of medical imaging, particularly in the diagnosis of solid tumors. His innovative work focuses on the development of novel compounds that enhance the detection of tumors in mammals.
Latest Patents
Rowland holds a patent for "Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors." This patent includes novel benzamide compounds of Formula (I), Formula (II), and Formula (III), along with their salts, water-soluble salts, analogs, and radiolabeled counterparts. The invention provides a method for diagnosing the presence of tumors in mammals by administering a diagnostic imaging detectable effective amount of these benzamide compounds. The compounds bind to tumors, allowing for effective imaging and diagnosis.
Career Highlights
Rowland is affiliated with Washington University, where he continues to advance research in medical imaging. His work has led to significant advancements in the understanding and diagnosis of tumors, contributing to better patient outcomes.
Collaborations
Rowland has collaborated with notable colleagues, including Robert H Mach and Michael John Welch. These partnerships have fostered innovation and enhanced the research capabilities within the field of medical imaging.
Conclusion
Douglas J Rowland, Jr. is a pioneering inventor whose work in tumor imaging has the potential to transform diagnostic practices in medicine. His contributions are vital for improving the detection and treatment of solid tumors, ultimately benefiting patient care.